Area of research
Endocrinology, Diabetes and Metabolism · Nephrology
Research interest
Research interests include Diabetes Treatment and Management, Chronic Kidney Disease and Diabetes, Iron Metabolism and Disorders, and Atrial Fibrillation Management and Outcomes.
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial
Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial